Velarion · Company Intelligence
Compensation Brief
Fiscal year 2024 · Filings through 2026-10-01

HOLOGIC INC (HOLX)

CEO Stephen MacMillan was paid $15,819,261 in fiscal year 2024, ↑ up 1.7% from fiscal year 2023, the 50th percentile of its disclosed peer group (SEC filing 0001140361-25-001287 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$15,819,261 ↑
Stephen MacMillan total, FY2024
50th
CEO pay percentile vs peers
137:1
CEO-to-median pay ratio
83.56%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Stephen MacMillan (Chairman, President and Chief Executive Officer), FY2024 total compensation $15,819,261 (base salary $1,212,628) [exec_comp, SEC accession 0001140361-25-001287, filed 2025-01-16]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

01

Summary Compensation Table — fiscal year 2024

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Stephen MacMillan$1,212,628$0$9,141,468$2,937,477$1,990,413$0$537,275$15,819,261
Chairman, President and Chief Executive Officer
Karleen Oberton694,23101,944,766624,995600,0000226,4464,090,438
Chief Financial Officer
Essex Mitchell592,69201,944,766624,995725,0000196,2724,083,725
Chief Operating Officer
Jan Verstreken693,39901,555,966499,996611,3230225,2113,585,895
Group President, International
John Griffin644,23101,555,966499,996550,0000223,8583,474,051
General Counsel

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2024 totalFY2023 totalFY2022 totalΔ FY2023→2024
Stephen MacMillan$15,819,261$15,555,032$14,335,632↑ +264,229
Karleen Oberton4,090,4383,934,6203,597,619↑ +155,818
Essex Mitchell4,083,7252,172,586—↑ +1,911,139
Jan Verstreken3,585,8953,523,9842,753,419↑ +61,911
John Griffin3,474,0513,341,1113,242,089↑ +132,940

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read HOLOGIC INC's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper HOLX reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the HOLOGIC INC Peer Teardown Report

$15,819,261 Stephen MacMillan total, FY2024

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of October 1, 2026 · Source: 0001140361-25-001287 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for HOLX

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
HOLXon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order HOLX

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against HOLX
41 companies name HOLX as a compensation peer

Each company listed discloses HOLX in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named HOLX in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Get the HOLOGIC INC Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2024 total
Amy M. WendellLead Independent Director$357,452
Charles J. DockendorffIndependent Director$354,952
Christiana StamoulisIndependent Director$329,952
Ludwig N. HantsonIndependent Director$329,952
Namal NawanaIndependent Director$45,000
Nanaz MohtashamiIndependent Director$329,952
Sally W. CrawfordIndependent Director$357,452
Scott T. GarrettIndependent Director$349,952
Stacey D. StewartIndependent Director$329,952
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Stephen P. MacMillanDirector2025-09-22D138,358$0$0Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2025-09-22D77,418675,190,103Deferred share awardForm 4 ↗
Stephen P. MacMillanDirector2025-09-22D22,240661,470,731Deferred share awardForm 4 ↗
Christiana StamoulisDirector2025-10-20D7,40200Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2025-10-20D7,40273540,864CommonForm 4 ↗
Christiana StamoulisDirector2025-10-20A7,40236266,768CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2025-11-04A2,656——CommonForm 4 ↗
Karleen ObertonChief Financial Officer2025-11-04A17,095——Deferred share awardForm 4 ↗
Jan VerstrekenGroup President, International2025-11-04A15,196——CommonForm 4 ↗
Stephen P. MacMillanDirector2025-11-04A83,589——Deferred share awardForm 4 ↗
Essex MitchellChief Operating Officer2025-11-04A9,116——CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2025-11-04A2,278——Deferred share awardForm 4 ↗
Anne M. LiddyGeneral Counsel2025-11-07D2887421,341CommonForm 4 ↗
Essex MitchellChief Operating Officer2025-11-07D3,92774290,991CommonForm 4 ↗
Karleen ObertonChief Financial Officer2025-11-07D9,42774698,541Deferred share awardForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2025-11-07D1587411,708CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2025-11-07D1387410,226CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2025-11-07D1,0787479,880CommonForm 4 ↗
Stephen P. MacMillanDirector2025-11-07D50,405743,735,011Deferred share awardForm 4 ↗
Jan VerstrekenGroup President, International2025-11-07D1,42074105,222CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2025-11-10A17,496——CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2025-11-10A13,458——Deferred share awardForm 4 ↗
Karleen ObertonChief Financial Officer2025-11-10A43,741——Deferred share awardForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2025-11-10A30,282——CommonForm 4 ↗
Stephen P. MacMillanDirector2025-11-10A169,582——Deferred share awardForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2025-11-10A5,047——CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2025-11-10A12,113——CommonForm 4 ↗
Jan VerstrekenGroup President, International2025-11-10A16,823——CommonForm 4 ↗
Essex MitchellChief Operating Officer2025-11-10A47,106——CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2025-11-11D2897521,559CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2025-11-11D4067530,288CommonForm 4 ↗
Essex MitchellChief Operating Officer2025-11-11D1,70175126,895CommonForm 4 ↗
Karleen ObertonChief Financial Officer2025-11-11D1,44975108,095Deferred share awardForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2025-11-11D7027552,369CommonForm 4 ↗
Jan VerstrekenGroup President, International2025-11-11D1787513,279CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2025-11-11D1817513,503CommonForm 4 ↗
Stephen P. MacMillanDirector2025-11-11D6,67975498,253Deferred share awardForm 4 ↗
Essex MitchellChief Operating Officer2025-11-14D1,3427499,509CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2025-11-14D1787413,199CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2025-11-14D3377424,989CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2025-11-14D1877413,866CommonForm 4 ↗
Karleen ObertonChief Financial Officer2025-11-14D1,3337498,842Deferred share awardForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2025-11-14D5617441,598CommonForm 4 ↗
Stephen P. MacMillanDirector2025-11-14D6,87474509,707Deferred share awardForm 4 ↗
Jan VerstrekenGroup President, International2025-11-14D1967414,533CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2025-12-12D90756,750CommonForm 4 ↗
De Walt DianaSVP, Human Resources2026-01-30D4,41675330,891CommonForm 4 ↗
De Walt DianaSVP, Human Resources2026-01-30D4,41675330,891CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-02-10D113758,492Deferred share awardForm 4 ↗
Nanaz MohtashamiDirector2026-02-26A3,190——CommonForm 4 ↗
Stacey D. StewartDirector2026-02-26A3,190——Deferred share awardForm 4 ↗
Martin MadausDirector2026-02-26A3,190——CommonForm 4 ↗
Wayde D. McMillanDirector2026-02-26A3,190——CommonForm 4 ↗
Amy M. WendellDirector2026-02-26A3,190——CommonForm 4 ↗
Christiana StamoulisDirector2026-02-26A3,190——CommonForm 4 ↗
Ludwig N. HantsonDirector2026-02-26A3,190——Deferred share awardForm 4 ↗
Charles J. DockendorffDirector2026-02-26A3,190——CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-02-27D1857513,942CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D16,146——Deferred share awardForm 4 ↗
Wayde D. McMillanDirector2026-04-07D4,932——CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D29,002——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D13,971——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D3,452——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D3,382——Derivative, Class A CommonForm 4 ↗
Martin MadausDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Stacey D. StewartDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D6,816——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07A3,452——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D5,665——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D3,505——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D7,132——Derivative, Class A CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D5,055——Derivative, Class A CommonForm 4 ↗
Martin MadausDirector2026-04-07D1,016——Derivative, Class A CommonForm 4 ↗
Nanaz MohtashamiDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Nanaz MohtashamiDirector2026-04-07D4,536——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D7,762——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D7,479——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D6,016——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D23,775——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D23,767——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D1,146,829——CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07D11,596——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D42,707——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D30,774——Derivative, Class A CommonForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07A22,598——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D17,964——CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D5,396——Derivative, Class A CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D2,012——Derivative, Class A CommonForm 4 ↗
Wayde D. McMillanDirector2026-04-07D5,171——Derivative, Class A CommonForm 4 ↗
Stacey D. StewartDirector2026-04-07D768——Derivative, Class A CommonForm 4 ↗
Stacey D. StewartDirector2026-04-07D8,358——Deferred share awardForm 4 ↗
Amy M. WendellDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D4,683——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07A42,707——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D21,743——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D150,735——Deferred share awardForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D12,490——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D159,339——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D6,523——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D1,500——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D3,505——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D23,026——Deferred share awardForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D5,943——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D8,432——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07A5,665——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07A7,762——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07A31,409——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07A190,400——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D19,327——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D17,831——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D12,509——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D15,387——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D7,564——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D134,039——CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D6,523——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D7,551——Derivative, Class A CommonForm 4 ↗
Stacey D. StewartDirector2026-04-07D4,536——Derivative, Class A CommonForm 4 ↗
Stacey D. StewartDirector2026-04-07D4,210——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D4,536——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D4,210——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D5,293——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D5,055——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D7,322——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D7,551——Derivative, Class A CommonForm 4 ↗
Amy M. WendellDirector2026-04-07D25,784——CommonForm 4 ↗
De Walt DianaSVP, Human Resources2026-04-07D7,603——CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D2,844——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D3,509——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D2,899——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D5,349——Derivative, Class A CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07A46,154——Derivative, Class A CommonForm 4 ↗
Mark W. HorvathPresident, Breast & Skeletal2026-04-07D2,490——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D3,509——Derivative, Class A CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D7,505——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D5,121——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D6,129——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D2,173——Derivative, Class A CommonForm 4 ↗
Anne M. LiddyGeneral Counsel2026-04-07D28,052——CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07D46,154——Derivative, Class A CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07D32,722——Derivative, Class A CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07D25,070——Derivative, Class A CommonForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07D18,698——Derivative, Class A CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07D2,972——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D28,047——Derivative, Class A CommonForm 4 ↗
Karleen ObertonChief Financial Officer2026-04-07D25,070——Derivative, Class A CommonForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07D10,028——Derivative, Class A CommonForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07D4,058——Derivative, Class A CommonForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07D3,804——Derivative, Class A CommonForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07D41,462——CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07A8,432——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D8,414——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D2,538——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D5,014——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D3,865——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D2,265——Derivative, Class A CommonForm 4 ↗
Brandon SchnittkerPresident, GYN Surgical2026-04-07D17,644——CommonForm 4 ↗
Benjamin Jordan CohnPrincipal Accounting Officer2026-04-07D10,861——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D5,293——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D7,322——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D6,523——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D6,626——CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D4,536——Derivative, Class A CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D4,210——Derivative, Class A CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D5,293——Derivative, Class A CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D6,523——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D190,400——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D117,829——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D106,300——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D118,877——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D160,565——Derivative, Class A CommonForm 4 ↗
Martin MadausDirector2026-04-07D5,445——CommonForm 4 ↗
Nanaz MohtashamiDirector2026-04-07D7,371——CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D4,210——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D31,409——Derivative, Class A CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D20,056——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D4,536——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D6,816——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D50,526——CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D5,293——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D5,055——Derivative, Class A CommonForm 4 ↗
Christiana StamoulisDirector2026-04-07D7,322——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D5,055——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D5,535——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D4,536——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D4,210——Derivative, Class A CommonForm 4 ↗
Charles J. DockendorffDirector2026-04-07D15,370——CommonForm 4 ↗
Essex MitchellChief Operating Officer2026-04-07D77,694——CommonForm 4 ↗
Ludwig N. HantsonDirector2026-04-07D7,322——Derivative, Class A CommonForm 4 ↗
Nanaz MohtashamiDirector2026-04-07D2,141——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D117,801——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D123,801——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D152,529——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D151,071——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D768,639——Derivative, Class A CommonForm 4 ↗
Martin MadausDirector2026-04-07D5,396——CommonForm 4 ↗
Jan VerstrekenGroup President, International2026-04-07D18,698——Derivative, Class A CommonForm 4 ↗
Stephen P. MacMillanDirector2026-04-07D1,423,837——Deferred share awardForm 4 ↗
Jennifer M. SchneidersPresident, Diag. Solutions2026-04-07D22,598——Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2024

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Jan VerstrekenPSU2023-11-141,7373,475—6,950$306,009
Karleen ObertonPSU2023-11-142,1714,343—8,686312,435
Essex MitchellPSU2023-11-142,1714,343—8,686312,435
Essex MitchellPSU2023-11-142,1714,343—8,686382,445
Stephen MacMillanPSU2023-11-1420,41640,832—81,6642,937,454
Karleen ObertonPSU2023-11-144,3438,687—17,374624,943
John GriffinPSU2023-11-143,4756,950—13,900499,983
John GriffinPSU2023-11-141,7373,475—6,950306,009
Karleen ObertonRSU2023-11-14——8,687—624,943
Jan VerstrekenPSU2023-11-141,7373,475—6,950249,992
Essex MitchellPSU2023-11-144,3438,687—17,374624,943
Karleen ObertonPSU2023-11-142,1714,343—8,686382,445
Essex MitchellRSU2023-11-14——8,687—624,943
Stephen MacMillanRSU2023-11-14——40,832—2,937,454
John GriffinPSU2023-11-141,7373,475—6,950249,992
Essex MitchellOPTION2023-11-14——25,070—624,995
Jan VerstrekenRSU2023-11-14——6,950—499,983
Stephen MacMillanPSU2023-11-1410,20820,416—40,8321,468,727
John GriffinRSU2023-11-14——6,950—499,983
Stephen MacMillanPSU2023-11-1410,20820,416—40,8321,797,833
Jan VerstrekenPSU2023-11-143,4756,950—13,900499,983
John GriffinOPTION2023-11-14——20,056—499,996
Stephen MacMillanOPTION2023-11-14——117,829—2,937,477
Jan VerstrekenOPTION2023-11-14——20,056—499,996
Karleen ObertonOPTION2023-11-14——25,070—624,995
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Jan Verstreken$499,983$1,055,984$499,99651.4%
Karleen Oberton624,9431,319,823624,99551.4%
Essex Mitchell624,9431,319,823624,99551.4%
Stephen MacMillan2,937,4546,204,0142,937,47751.4%
John Griffin499,9831,055,984499,99651.4%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2024

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Karleen ObertonPSU17,374—$1,404,167
Essex MitchellRSU2,690—217,406
Jan VerstrekenRSU1,758—142,082
Stephen MacMillanRSU34,209—2,764,792
Jan VerstrekenRSU5,130—414,642
Essex MitchellOption8,69774.35—
John GriffinPSU13,900—1,123,398
Stephen MacMillanPSU73,974—5,978,579
John GriffinRSU2,050—165,681
Stephen MacMillanPSU40,832—3,300,042
Stephen MacMillanRSU40,832—3,300,042
John GriffinPSU12,104—978,245
Stephen MacMillanPSU81,664—6,600,084
Stephen MacMillanRSU46,862—3,787,387
Essex MitchellPSU8,068—652,056
Stephen MacMillanRSU37,490—3,029,909
Stephen MacMillanPSU36,986—2,989,209
Stephen MacMillanRSU24,658—1,992,860
Essex MitchellPSU17,374—1,404,167
Karleen ObertonPSU15,130—1,222,807
Jan VerstrekenPSU13,900—1,123,398
Jan VerstrekenPSU13,448—1,086,867
Stephen MacMillanRSU11,716—946,887
Karleen ObertonRSU9,372—757,445
Karleen ObertonRSU8,687—702,083
Essex MitchellRSU8,687—702,083
Karleen ObertonPSU8,686—702,003
Karleen ObertonOption5,94268.35—
Essex MitchellPSU8,686—702,003
John GriffinRSU8,200—662,724
Karleen ObertonPSU7,564—611,322
Karleen ObertonRSU7,498—605,956
Jan VerstrekenRSU7,028—568,003
John GriffinRSU6,950—561,699
John GriffinPSU6,950—561,699
Jan VerstrekenRSU6,950—561,699
Jan VerstrekenPSU6,950—561,699
John GriffinOption5,31768.35—
Karleen ObertonRSU6,842—552,935
Jan VerstrekenPSU6,724—543,434
Jan VerstrekenOption20,05671.94—
John GriffinRSU6,560—530,179
John GriffinPSU6,052—489,123
John GriffinRSU5,986—483,789
Karleen ObertonRSU2,343—189,361
Jan VerstrekenRSU5,622—454,402
Karleen ObertonRSU5,044—407,656
Essex MitchellRSU4,686—378,723
Jan VerstrekenRSU4,483—362,316
John GriffinRSU4,035—326,109
Essex MitchellPSU4,034—326,028
Essex MitchellRSU3,749—302,978
Karleen ObertonOption16,30874.35—
Essex MitchellRSU3,421—276,467
Essex MitchellRSU1,172—94,721
Stephen MacMillanOption30,95168.35—
Stephen MacMillanOption59,43971.13—
Stephen MacMillanOption79,72574.35—
Stephen MacMillanOption117,82971.94—
Karleen ObertonOption11,88871.13—
Karleen ObertonOption25,07071.94—
Essex MitchellOption1,87768.35—
Jan VerstrekenOption3,12868.35—
Essex MitchellOption5,94471.13—
Essex MitchellOption25,07071.94—
John GriffinOption10,40271.13—
John GriffinOption13,04674.35—
John GriffinOption20,05671.94—
Jan VerstrekenOption8,91671.13—
Jan VerstrekenOption14,49674.35—
05

Incentive-plan design — the Compensation Discussion & Analysis

Hologic's compensation program is guided by principles of pay for performance, competitive pay, and a focus on total direct compensation. The design aims to motivate high performance within an entrepreneurial culture, ensure target compensation is competitive with peers, and support leadership talent through a mix of fixed and variable pay.

CEO STI target (% of salary)150%
CEO LTI target (% of salary)—
Independent consultantPearl Meyer & Partners, LLC
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20252025-02-26169,811,16033,412,544224,94483.56%Passed
20242024-03-07157,469,57842,018,967210,44878.94%Passed
20232023-03-09167,512,93149,838,936429,64477.07%Passed
20222022-03-10150,939,07563,245,865846,61070.47%Passed
20212021-03-11154,538,68069,327,387546,59569.03%Passed
20202020-03-05185,555,44439,060,8281,687,89982.61%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20252025-02-2683.56%a
20242024-03-0778.94%b
20232023-03-0977.07%c

a. Approved under the standard stated in the filing — “Abstentions and broker "non-votes" are included in the number of shares present or represented for purposes of quorum but are disregarded for purposes of determining whether any of the proposals have been approved.”.

b. Approved under the standard stated in the filing — “Abstentions and broker "non-votes" are included in the number of shares present or represented for purposes of quorum but are disregarded for purposes of determining whether any of the proposals have been approved.”.

c. Approved under the standard stated in the filing — “Abstentions and broker "non-votes" are included in the number of shares present or represented for purposes of quorum but are disregarded for purposes of determining whether any of the proposals have been approved.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)137 : 1
CEO total compensation$12,040,142
Median employee compensation$87,845
08

Director compensation — fiscal year 2024

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Amy M. WendellIndependent · Lead Independent Director · Compensation · Nominating and Corporate Governance (Chair)$117,500$119,975$119,977——$357,452
Sally W. CrawfordIndependent · Compensation · Nominating and Corporate Governance · Not standing for re-election117,500119,975119,977——357,452
Charles J. DockendorffIndependent · Audit and Finance (Chair)115,000119,975119,977——354,952
Scott T. GarrettIndependent · Compensation (Chair) · Nominating and Corporate Governance · Not standing for re-election110,000119,975119,977——349,952
Stacey D. StewartIndependent · Audit and Finance90,000119,975119,977——329,952
Nanaz MohtashamiIndependent · Compensation · Nominating and Corporate Governance90,000119,975119,977——329,952
Christiana StamoulisIndependent · Audit and Finance90,000119,975119,977——329,952
Ludwig N. HantsonIndependent · Compensation · Nominating and Corporate Governance90,000119,975119,977——329,952
Namal NawanaIndependent · Not standing for re-election45,00000——45,000
Stephen P. MacMillanEmployee director · Board Chair—————0
Martin MadausIndependent · Compensation · Nominating and Corporate Governance · Newly elected——————
09

Board fee structure and ownership guideline

Annual cash retainer$90,000
Annual equity retainer$240,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 15,000
Stock ownership guideline5x annual base cash retainer
09b

Total cost of the board

ComponentFY2024
Cash retainers and fees$865,000
Equity awards (grant-date value)$959,800
All other compensation$0
Total cost of the board$1,824,800

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2024

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies HOLOGIC INC names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including HOLOGIC INC.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Thermo Fisher Scientific Inc.2025Marc Casper$1,785,534$65,730,211$7,951,377$3,742,123$79,923,350
2Johnson & Johnson2025Joaquin Duato1,600,00015,028,9485,927,9954,298,70032,758,111
3Baxter International Inc.2025Andrew Hider499,31523,133,5183,185,053820,12529,805,182
4Abbott Laboratories2025Robert Ford1,500,0008,787,3788,788,4301,968,75024,198,660
5Boston Scientific Corporation2025Michael Mahoney1,442,60313,608,0563,749,9804,002,00123,532,050
6Stryker Corporation2025Kevin Lobo1,500,0009,764,1366,920,7812,250,00021,401,495
7Intuitive Surgical, Inc.2025David Rosa858,75018,674,87201,373,85920,997,480
8Edwards Lifesciences Corp.2025Bernard Zovighian1,192,5007,167,0246,499,1092,406,53717,454,255
9Becton, Dickinson and Company2025Thomas Polen1,395,4639,991,8543,311,8611,852,01017,129,140
10ResMed Inc.2026Michael Farrell1,272,8959,749,4683,249,9071,738,85716,201,649
11Zimmer Biomet Holdings, Inc.2025Ivan Tornos1,281,84612,000,10102,420,76716,106,550
12The Cooper Companies, Inc.2025Albert White III1,170,7696,642,9186,643,0501,525,95116,051,141
13HOLOGIC INC2024Stephen MacMillan1,212,6289,141,4682,937,4771,990,41315,819,261
14Quest Diagnostics Inc.2025James Davis1,250,0008,762,8612,999,8732,205,84415,498,479
15IDEXX Laboratories, Inc.2025Jonathan Mazelsky1,150,0005,399,8815,400,0012,593,00014,580,122
16Waters Corporation2025Udit Batra1,150,0007,430,2472,999,9222,371,87513,973,044
17Revvity, Inc.2025Prahlad R. Singh1,129,2317,694,9852,559,1522,385,45013,809,549
18Agilent Technologies, Inc.2025Padraig McDonnell1,141,3458,169,8502,017,7591,436,80912,827,236
19STERIS plc2026Daniel Carestio1,095,7074,333,9514,334,2511,725,00711,508,522
20Illumina, Inc.2025Jacob Thaysen1,000,0008,763,12201,155,00011,018,895
21Integra LifeSciences Holdings Corp2025Mojdeh Poul1,009,6165,219,8682,250,011174,5639,375,551
22DENTSPLY SIRONA Inc.2025Daniel Scavilla431,7533,484,4883,221,523437,1508,760,139
23DexCom, Inc.2025Jacob Leach768,9625,936,06201,164,7807,985,960
24Mettler-Toledo International Inc.2025Patrick Kaltenbach1,145,9993,267,8081,635,033462,9846,741,212
25Teleflex Incorporated2025Liam Kelly1,144,4002,005,6042,886,518227,2806,732,419
26Bruker Corporation2025Frank Laukien976,5541,623,4071,488,109587,2704,706,388
—Qiagen NV——————not in coverage universe

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
HOLOGIC INC109%PSU 50 · RSU 25 · Option 25NoPearl Meyer & Partners, LLC
Abbott Laboratories75.0%Options 50 · PSU 50NoMeridian Compensation Partners, LLC
Agilent Technologies, Inc.not disclosedPSU 60 · Options 20 · RSU 20NoSemler Brossy
Baxter International Inc.not disclosednot disclosedNoAon Consulting, Inc. (Aon)
Becton, Dickinson and Company85%PSU 50 · Options 25 · RSU 25NoSemler Brossy
Boston Scientific Corporation173%PSU 50 · RSU 25 · Options 25NoSemler Brossy Consulting Group, LLC
Bruker Corporation43.0%RSU 52 · Options 48not disclosedAon's Human Capital Solutions Practice
DENTSPLY SIRONA Inc.66%PSU 50 · Options 50NoFrederic W. Cook & Co., Inc.
DexCom, Inc.not disclosednot disclosedYes — Relative TSR Performance MetricAon Hewitt Consulting Company
Edwards Lifesciences Corp.127%Options 50 · PSU 25 · RSU 25NoSemler Brossy Consulting Group
IDEXX Laboratories, Inc.140%Options 50 · PSU 50NoFarient
Illumina, Inc.1155%not disclosedYes — 3-year rTSR performance against select companies in the Nasdaq Biotechnology IndexAon (Aon's Human Capital Practice, a division of Aon, plc)
Integra LifeSciences Holdings Corp40%PSU 50 · Options 25 · RSU 25NoWTW
Intuitive Surgical, Inc.115.2%RSU 50 · PSU 50NoAon
Johnson & Johnsonnot disclosednot disclosedYes — Relative TSRSemler Brossy Consulting Group
Mettler-Toledo International Inc.not disclosednot disclosedYes — Relative Total Shareholder Return (rTSR)Pearl Meyer & Partners
Qiagen NVnot disclosednot disclosednot disclosednot disclosed
Quest Diagnostics Inc.113.9%PSU 50 · RSU 25 · Options 25Yes — Relative TSRSemler Brossy
ResMed Inc.not disclosedPSU 50 · RSU 25 · Options 25Yes — Relative TSRFW Cook
Revvity, Inc.124%PSU 50 · RSU 25 · Options 25NoPearl Meyer
STERIS plc125.1%RSU 50 · Options 50not disclosedFrederic W. Cook & Co., Inc.
Stryker Corporation100%PSU 48 · Options 34NoSemler Brossy
Teleflex Incorporated25.9%Options 55 · RSU 25 · PSU 20Yes — Absolute TSRFW Cook
The Cooper Companies, Inc.100.9%Options 50 · PSU 50NoCompensia
Thermo Fisher Scientific Inc.99.8%PSU 50 · Options 50Yes — Relative TSRPearl Meyer
Waters Corporation110%PSU 50 · Options 35 · RSU 15Yes — Relative Total Shareholder Return (rTSR)Pearl Meyer
Zimmer Biomet Holdings, Inc.125.9%RSU 50 · PSU 50Yes — Relative TSRSemler Brossy

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at HOLOGIC INC in fiscal 2024?
As disclosed, Stephen MacMillan (Chairman, President and Chief Executive Officer) was the highest-paid executive at HOLOGIC INC in fiscal 2024, with total compensation of $15,819,261.
How does HOLOGIC INC's chief executive pay compare to its disclosed peer group?
As disclosed, Stephen MacMillan's total compensation ranked at the 50th percentile of HOLOGIC INC's disclosed peer group.
What is HOLOGIC INC's CEO-to-median employee pay ratio?
As disclosed, HOLOGIC INC's CEO-to-median employee pay ratio was 137:1.
How did shareholders vote on HOLOGIC INC's executive compensation?
As disclosed, 83.56% of shareholders supported HOLOGIC INC's executive compensation in the latest say-on-pay vote.
How much does HOLOGIC INC spend in total on board compensation for fiscal 2024?
As disclosed, HOLOGIC INC reported total board compensation of $1,824,800 for fiscal 2024.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Stephen MacMillanDEF 14A2025-01-160001140361-25-001287Section “Summary Compensation Table”. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674
2Section 01, Karleen ObertonDEF 14A2025-01-160001140361-25-001287Section “Summary Compensation Table”. As printed: 4,090,438. Filing ↗machine: r5 · c25 · span 1564568–1564577
3Section 01, Essex MitchellDEF 14A2025-01-160001140361-25-001287Section “Summary Compensation Table”. As printed: 4,083,725. Filing ↗machine: r8 · c25 · span 1580010–1580019
4Section 01, Jan VerstrekenDEF 14A2025-01-160001140361-25-001287Section “Summary Compensation Table”. As printed: 3,585,895. Filing ↗machine: r13 · c25 · span 1605785–1605794
5Section 01, John GriffinDEF 14A2025-01-160001140361-25-001287Section “Summary Compensation Table”. As printed: 3,474,051. Filing ↗machine: r10 · c25 · span 1590421–1590430
6Section 03, Jan Verstreken PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r30 · c19 · span 1847820–1847825
7Section 03, Karleen Oberton PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r12 · c19 · span 1722083–1722088
8Section 03, Essex Mitchell PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r18 · c19 · span 1763979–1763984
9Section 03, Essex Mitchell PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r18 · c19 · span 1763979–1763984
10Section 03, Stephen MacMillan PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r4 · c28 · span 1668498–1668504
11Section 03, Karleen Oberton PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r10 · c28 · span 1709819–1709824
12Section 03, John Griffin PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r22 · c28 · span 1793649–1793654
13Section 03, John Griffin PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r24 · c19 · span 1805913–1805918
14Section 03, Karleen Oberton RSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r10 · c28 · span 1709819–1709824
15Section 03, Jan Verstreken PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r30 · c19 · span 1847820–1847825
16Section 03, Essex Mitchell PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r16 · c28 · span 1751715–1751720
17Section 03, Karleen Oberton PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r12 · c19 · span 1722083–1722088
18Section 03, Essex Mitchell RSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r16 · c28 · span 1751715–1751720
19Section 03, Stephen MacMillan RSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r4 · c28 · span 1668498–1668504
20Section 03, John Griffin PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r24 · c19 · span 1805913–1805918
21Section 03, Essex Mitchell OPTIONDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r17 · c31 · span 1759101–1759107
22Section 03, Jan Verstreken RSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r28 · c28 · span 1835556–1835561
23Section 03, Stephen MacMillan PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r6 · c19 · span 1680599–1680605
24Section 03, John Griffin RSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r22 · c28 · span 1793649–1793654
25Section 03, Stephen MacMillan PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r6 · c19 · span 1680599–1680605
26Section 03, Jan Verstreken PSUDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r28 · c28 · span 1835556–1835561
27Section 03, John Griffin OPTIONDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r23 · c31 · span 1801035–1801041
28Section 03, Stephen MacMillan OPTIONDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r5 · c31 · span 1675802–1675809
29Section 03, Jan Verstreken OPTIONDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r29 · c31 · span 1842942–1842948
30Section 03, Karleen Oberton OPTIONDEF 14A2025-01-160001140361-25-001287Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t249 · r11 · c31 · span 1717205–1717211
31Section 07, pay ratioDEF 14A2019-01-180001206774-19-000140Section “CEO Pay Ratio”. As printed: 137 : 1. Filing ↗
32Section 08, Amy M. WendellDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 357,452. Filing ↗machine: span 838853–839027
33Section 08, Sally W. CrawfordDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 357,452. Filing ↗machine: span 816299–816473
34Section 08, Charles J. DockendorffDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 354,952. Filing ↗machine: span 819151–819326
35Section 08, Scott T. GarrettDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 349,952. Filing ↗machine: span 822013–822188
36Section 08, Stacey D. StewartDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 329,952. Filing ↗machine: span 836604–836779
37Section 08, Nanaz MohtashamiDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 329,952. Filing ↗machine: span 827792–827967
38Section 08, Christiana StamoulisDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 329,952. Filing ↗machine: span 833714–833889
39Section 08, Ludwig N. HantsonDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 329,952. Filing ↗machine: span 824903–825078
40Section 08, Namal NawanaDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 45,000. Filing ↗machine: span 828942–829161
41Section 08, Stephen P. MacMillanDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: 0. Filing ↗
42Section 08, Martin MadausDEF 14A2025-01-160001140361-25-001287Section “Director Compensation”. As printed: —. Filing ↗
43Section 02, Stephen P. MacMillan 2025-09-22Form 42025-09-230000859737-25-000028Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Stephen P. MacMillan 2025-09-22Form 42025-09-230000859737-25-000028Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Stephen P. MacMillan 2025-09-22Form 42025-09-230000859737-25-000028Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Christiana Stamoulis 2025-10-20Form 42025-10-220000859737-25-000030Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Christiana Stamoulis 2025-10-20Form 42025-10-220000859737-25-000030Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Christiana Stamoulis 2025-10-20Form 42025-10-220000859737-25-000030Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Benjamin Jordan Cohn 2025-11-04Form 42025-11-060000859737-25-000032Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Karleen Oberton 2025-11-04Form 42025-11-060000859737-25-000042Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Jan Verstreken 2025-11-04Form 42025-11-060000859737-25-000044Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Stephen P. MacMillan 2025-11-04Form 42025-11-060000859737-25-000046Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Essex Mitchell 2025-11-04Form 42025-11-060000859737-25-000037Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Mark W. Horvath 2025-11-04Form 42025-11-060000859737-25-000035Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Anne M. Liddy 2025-11-07Form 42025-11-120000859737-25-000048Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Essex Mitchell 2025-11-07Form 42025-11-120000859737-25-000052Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Karleen Oberton 2025-11-07Form 42025-11-120000859737-25-000054Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Jennifer M. Schneiders 2025-11-07Form 42025-11-120000859737-25-000056Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Brandon Schnittker 2025-11-07Form 42025-11-120000859737-25-000058Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Benjamin Jordan Cohn 2025-11-07Form 42025-11-120000859737-25-000062Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Stephen P. MacMillan 2025-11-07Form 42025-11-120000859737-25-000064Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Jan Verstreken 2025-11-07Form 42025-11-120000859737-25-000060Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Anne M. Liddy 2025-11-10Form 42025-11-120000859737-25-000048Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Mark W. Horvath 2025-11-10Form 42025-11-120000859737-25-000050Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Karleen Oberton 2025-11-10Form 42025-11-120000859737-25-000054Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Jennifer M. Schneiders 2025-11-10Form 42025-11-120000859737-25-000056Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Stephen P. MacMillan 2025-11-10Form 42025-11-120000859737-25-000064Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Benjamin Jordan Cohn 2025-11-10Form 42025-11-120000859737-25-000062Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Brandon Schnittker 2025-11-10Form 42025-11-120000859737-25-000058Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Jan Verstreken 2025-11-10Form 42025-11-120000859737-25-000060Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Essex Mitchell 2025-11-10Form 42025-11-120000859737-25-000052Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Brandon Schnittker 2025-11-11Form 42025-11-120000859737-25-000058Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Anne M. Liddy 2025-11-11Form 42025-11-120000859737-25-000048Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Essex Mitchell 2025-11-11Form 42025-11-120000859737-25-000052Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Karleen Oberton 2025-11-11Form 42025-11-120000859737-25-000054Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Jennifer M. Schneiders 2025-11-11Form 42025-11-120000859737-25-000056Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Jan Verstreken 2025-11-11Form 42025-11-120000859737-25-000060Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Benjamin Jordan Cohn 2025-11-11Form 42025-11-120000859737-25-000062Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Stephen P. MacMillan 2025-11-11Form 42025-11-120000859737-25-000064Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Essex Mitchell 2025-11-14Form 42025-11-180000859737-25-000078Insider equity transaction reported since the proxy statement. Filing ↗
81Section 02, Brandon Schnittker 2025-11-14Form 42025-11-180000859737-25-000084Insider equity transaction reported since the proxy statement. Filing ↗
82Section 02, Anne M. Liddy 2025-11-14Form 42025-11-180000859737-25-000076Insider equity transaction reported since the proxy statement. Filing ↗
83Section 02, Benjamin Jordan Cohn 2025-11-14Form 42025-11-180000859737-25-000074Insider equity transaction reported since the proxy statement. Filing ↗
84Section 02, Karleen Oberton 2025-11-14Form 42025-11-180000859737-25-000080Insider equity transaction reported since the proxy statement. Filing ↗
85Section 02, Jennifer M. Schneiders 2025-11-14Form 42025-11-180000859737-25-000082Insider equity transaction reported since the proxy statement. Filing ↗
86Section 02, Stephen P. MacMillan 2025-11-14Form 42025-11-180000859737-25-000088Insider equity transaction reported since the proxy statement. Filing ↗
87Section 02, Jan Verstreken 2025-11-14Form 42025-11-180000859737-25-000086Insider equity transaction reported since the proxy statement. Filing ↗
88Section 02, Brandon Schnittker 2025-12-12Form 42025-12-160000859737-25-000090Insider equity transaction reported since the proxy statement. Filing ↗
89Section 02, De Walt Diana 2026-01-30Form 42026-02-030000859737-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
90Section 02, De Walt Diana 2026-01-30Form 42026-02-030000859737-26-000013Insider equity transaction reported since the proxy statement. Filing ↗
91Section 02, Mark W. Horvath 2026-02-10Form 42026-02-120000859737-26-000015Insider equity transaction reported since the proxy statement. Filing ↗
92Section 02, Nanaz Mohtashami 2026-02-26Form 42026-03-020000859737-26-000025Insider equity transaction reported since the proxy statement. Filing ↗
93Section 02, Stacey D. Stewart 2026-02-26Form 42026-03-020000859737-26-000029Insider equity transaction reported since the proxy statement. Filing ↗
94Section 02, Martin Madaus 2026-02-26Form 42026-03-020000859737-26-000021Insider equity transaction reported since the proxy statement. Filing ↗
95Section 02, Wayde D. McMillan 2026-02-26Form 42026-03-020000859737-26-000023Insider equity transaction reported since the proxy statement. Filing ↗
96Section 02, Amy M. Wendell 2026-02-26Form 42026-03-020000859737-26-000031Insider equity transaction reported since the proxy statement. Filing ↗
97Section 02, Christiana Stamoulis 2026-02-26Form 42026-03-020000859737-26-000027Insider equity transaction reported since the proxy statement. Filing ↗
98Section 02, Ludwig N. Hantson 2026-02-26Form 42026-03-020000859737-26-000019Insider equity transaction reported since the proxy statement. Filing ↗
99Section 02, Charles J. Dockendorff 2026-02-26Form 42026-03-020000859737-26-000017Insider equity transaction reported since the proxy statement. Filing ↗
100Section 02, Anne M. Liddy 2026-02-27Form 42026-03-020000859737-26-000033Insider equity transaction reported since the proxy statement. Filing ↗
101Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
102Section 02, Wayde D. McMillan 2026-04-07Form 42026-04-090000859737-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
103Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
104Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
105Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
106Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
107Section 02, Martin Madaus 2026-04-07Form 42026-04-090000859737-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
108Section 02, Stacey D. Stewart 2026-04-07Form 42026-04-090000859737-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
109Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
110Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
111Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
112Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
113Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
114Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
115Section 02, Martin Madaus 2026-04-07Form 42026-04-090000859737-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
116Section 02, Nanaz Mohtashami 2026-04-07Form 42026-04-090000859737-26-000071Insider equity transaction reported since the proxy statement. Filing ↗
117Section 02, Nanaz Mohtashami 2026-04-07Form 42026-04-090000859737-26-000071Insider equity transaction reported since the proxy statement. Filing ↗
118Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
119Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
120Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
121Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
122Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
123Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
124Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
125Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
126Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
127Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
128Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
129Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
130Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
131Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
132Section 02, Wayde D. McMillan 2026-04-07Form 42026-04-090000859737-26-000069Insider equity transaction reported since the proxy statement. Filing ↗
133Section 02, Stacey D. Stewart 2026-04-07Form 42026-04-090000859737-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
134Section 02, Stacey D. Stewart 2026-04-07Form 42026-04-090000859737-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
135Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
136Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
137Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
138Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
139Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
140Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
141Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
142Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
143Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
144Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
145Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
146Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
147Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
148Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
149Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
150Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
151Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
152Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
153Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
154Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
155Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
156Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
157Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
158Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
159Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
160Section 02, Stacey D. Stewart 2026-04-07Form 42026-04-090000859737-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
161Section 02, Stacey D. Stewart 2026-04-07Form 42026-04-090000859737-26-000075Insider equity transaction reported since the proxy statement. Filing ↗
162Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
163Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
164Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
165Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
166Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
167Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
168Section 02, Amy M. Wendell 2026-04-07Form 42026-04-090000859737-26-000077Insider equity transaction reported since the proxy statement. Filing ↗
169Section 02, De Walt Diana 2026-04-07Form 42026-04-090000859737-26-000079Insider equity transaction reported since the proxy statement. Filing ↗
170Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
171Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
172Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
173Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
174Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
175Section 02, Mark W. Horvath 2026-04-07Form 42026-04-090000859737-26-000081Insider equity transaction reported since the proxy statement. Filing ↗
176Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
177Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
178Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
179Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
180Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
181Section 02, Anne M. Liddy 2026-04-07Form 42026-04-090000859737-26-000083Insider equity transaction reported since the proxy statement. Filing ↗
182Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
183Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
184Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
185Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
186Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
187Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
188Section 02, Karleen Oberton 2026-04-07Form 42026-04-090000859737-26-000087Insider equity transaction reported since the proxy statement. Filing ↗
189Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
190Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
191Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
192Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
193Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
194Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
195Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
196Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
197Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
198Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
199Section 02, Brandon Schnittker 2026-04-07Form 42026-04-090000859737-26-000091Insider equity transaction reported since the proxy statement. Filing ↗
200Section 02, Benjamin Jordan Cohn 2026-04-07Form 42026-04-090000859737-26-000059Insider equity transaction reported since the proxy statement. Filing ↗
201Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
202Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
203Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
204Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
205Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
206Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
207Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
208Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
209Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
210Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
211Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
212Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
213Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
214Section 02, Martin Madaus 2026-04-07Form 42026-04-090000859737-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
215Section 02, Nanaz Mohtashami 2026-04-07Form 42026-04-090000859737-26-000071Insider equity transaction reported since the proxy statement. Filing ↗
216Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
217Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
218Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
219Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
220Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
221Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
222Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
223Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
224Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
225Section 02, Christiana Stamoulis 2026-04-07Form 42026-04-090000859737-26-000073Insider equity transaction reported since the proxy statement. Filing ↗
226Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
227Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
228Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
229Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
230Section 02, Charles J. Dockendorff 2026-04-07Form 42026-04-090000859737-26-000061Insider equity transaction reported since the proxy statement. Filing ↗
231Section 02, Essex Mitchell 2026-04-07Form 42026-04-090000859737-26-000085Insider equity transaction reported since the proxy statement. Filing ↗
232Section 02, Ludwig N. Hantson 2026-04-07Form 42026-04-090000859737-26-000063Insider equity transaction reported since the proxy statement. Filing ↗
233Section 02, Nanaz Mohtashami 2026-04-07Form 42026-04-090000859737-26-000071Insider equity transaction reported since the proxy statement. Filing ↗
234Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
235Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
236Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
237Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
238Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
239Section 02, Martin Madaus 2026-04-07Form 42026-04-090000859737-26-000067Insider equity transaction reported since the proxy statement. Filing ↗
240Section 02, Jan Verstreken 2026-04-07Form 42026-04-090000859737-26-000093Insider equity transaction reported since the proxy statement. Filing ↗
241Section 02, Stephen P. MacMillan 2026-04-07Form 42026-04-090000859737-26-000065Insider equity transaction reported since the proxy statement. Filing ↗
242Section 02, Jennifer M. Schneiders 2026-04-07Form 42026-04-090000859737-26-000089Insider equity transaction reported since the proxy statement. Filing ↗
243Section 06, 2025 voteForm 8-K2025-02-280001140361-25-006521Item 5.07 · say-on-pay result. As reported: 83.56% (votes for as printed: 169,811,160). Filing ↗
244Section 06, 2024 voteForm 8-K2024-03-120000859737-24-000009Item 5.07 · say-on-pay result. As reported: 78.94% (votes for as printed: 157,469,578). Filing ↗
245Section 06, 2023 voteForm 8-K2023-03-100000859737-23-000006Item 5.07 · say-on-pay result. As reported: 77.07% (votes for as printed: 167,512,931). Filing ↗
246Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
247Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
248Section 09b board cost (computed)Computed——Cash 865,000 + equity 959,800 + all other 0 = 1,824,800, summed across the director compensation table rows.machine: formula: Σ = 1,824,800
249Thermo Fisher Scientific Inc., Section 10b CEO totalDEF 14A2026-04-070001193125-26-144585CEO total compensation as printed in Thermo Fisher Scientific Inc.'s own proxy. As printed: 79,923,350. Filing ↗machine: span 973487–973497
250Johnson & Johnson, Section 10b CEO totalDEF 14A2026-03-110000200406-26-000063CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. Filing ↗machine: r3 · c27 · span 1621235–1621246
251Baxter International Inc., Section 10b CEO totalDEF 14A2026-03-230001628280-26-020330CEO total compensation as printed in Baxter International Inc.'s own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076
252Abbott Laboratories, Section 10b CEO totalDEF 14A2026-03-130001308179-26-000064CEO total compensation as printed in Abbott Laboratories's own proxy. As printed: 24,198,660. Filing ↗machine: span 1245488–1245498
253Boston Scientific Corporation, Section 10b CEO totalDEF 14A2026-03-180000885725-26-000025CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. Filing ↗machine: r2 · c27 · span 1249807–1249817
254Stryker Corporation, Section 10b CEO totalDEF 14A2026-03-230000310764-26-000013CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989
255Intuitive Surgical, Inc., Section 10b CEO totalDEF 14A2026-03-130001035267-26-000023CEO total compensation as printed in Intuitive Surgical, Inc.'s own proxy. As printed: 20,997,480. Filing ↗machine: r2 · c48 · span 762289–762299
256Edwards Lifesciences Corp., Section 10b CEO totalDEF 14A2026-03-260001099800-26-000015CEO total compensation as printed in Edwards Lifesciences Corp.'s own proxy. As printed: 17,454,255. Filing ↗machine: r2 · c27 · span 965441–965451
257Becton, Dickinson and Company, Section 10b CEO totalDEF 14A2025-12-180001628280-25-057846CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295
258ResMed Inc., Section 10b CEO totalDEF 14A2026-10-010000943819-26-000080CEO total compensation as printed in ResMed Inc.'s own proxy. As printed: 16,201,649. Filing ↗machine: span 1267106–1267116
259Zimmer Biomet Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-010001193125-26-135661CEO total compensation as printed in Zimmer Biomet Holdings, Inc.'s own proxy. As printed: 16,106,550. Filing ↗machine: t111 · r3 · c16 · span 1895785–1895795
260The Cooper Companies, Inc., Section 10b CEO totalDEF 14A2026-02-240001628280-26-011110CEO total compensation as printed in The Cooper Companies, Inc.'s own proxy. As printed: 16,051,141. Filing ↗machine: t120 · r3 · c14 · span 744904–744914
261HOLOGIC INC (subject), Section 10b CEO totalDEF 14A2025-01-160001140361-25-001287CEO total compensation as printed in HOLOGIC INC's own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674
262Quest Diagnostics Inc., Section 10b CEO totalDEF 14A2026-04-060001140361-26-013356CEO total compensation as printed in Quest Diagnostics Inc.'s own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337
263IDEXX Laboratories, Inc., Section 10b CEO totalDEF 14A2026-03-270000874716-26-000064CEO total compensation as printed in IDEXX Laboratories, Inc.'s own proxy. As printed: 14,580,122. Filing ↗machine: span 1576008–1576018
264Waters Corporation, Section 10b CEO totalDEF 14A2026-04-090001193125-26-149657CEO total compensation as printed in Waters Corporation's own proxy. As printed: 13,973,044. Filing ↗machine: r5 · c18 · span 568522–568533
265Revvity, Inc., Section 10b CEO totalDEF 14A2026-03-160001193125-26-107266CEO total compensation as printed in Revvity, Inc.'s own proxy. As printed: 13,809,549. Filing ↗machine: r3 · c39 · span 751285–751295
266Agilent Technologies, Inc., Section 10b CEO totalDEF 14A2026-02-060001193125-26-040286CEO total compensation as printed in Agilent Technologies, Inc.'s own proxy. As printed: 12,827,236. Filing ↗machine: r3 · c29 · span 1450982–1450992
267STERIS plc, Section 10b CEO totalDEF 14A2026-06-110001193125-26-267599CEO total compensation as printed in STERIS plc's own proxy. As printed: 11,508,522. Filing ↗machine: t172 · r6 · c34 · span 820590–820600
268Illumina, Inc., Section 10b CEO totalDEF 14A2026-04-090001193125-26-149669CEO total compensation as printed in Illumina, Inc.'s own proxy. As printed: 11,018,895. Filing ↗machine: r4 · c14 · span 728526–728536
269Integra LifeSciences Holdings Corp, Section 10b CEO totalDEF 14A2026-04-060000917520-26-000015CEO total compensation as printed in Integra LifeSciences Holdings Corp's own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213
270DENTSPLY SIRONA Inc., Section 10b CEO totalDEF 14A2026-04-230000818479-26-000125CEO total compensation as printed in DENTSPLY SIRONA Inc.'s own proxy. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387
271DexCom, Inc., Section 10b CEO totalDEF 14A2026-04-150001093557-26-000061CEO total compensation as printed in DexCom, Inc.'s own proxy. As printed: 7,985,960. Filing ↗machine: span 940364–940373
272Mettler-Toledo International Inc., Section 10b CEO totalDEF 14A2026-03-180001174947-26-000389CEO total compensation as printed in Mettler-Toledo International Inc.'s own proxy. As printed: 6,741,212. Filing ↗machine: r2 · c7 · span 643529–643538
273Teleflex Incorporated, Section 10b CEO totalDEF 14A2026-04-130000096943-26-000039CEO total compensation as printed in Teleflex Incorporated's own proxy. As printed: 6,732,419. Filing ↗machine: span 558736–558745
274Bruker Corporation, Section 10b CEO totalDEF 14A2026-04-100001193125-26-151305CEO total compensation as printed in Bruker Corporation's own proxy. As printed: 4,706,388. Filing ↗machine: t77 · r2 · c18 · span 987303–987312
275Section 10a, Revvity, Inc. reciprocityDEF 14A—0001193125-26-107266Revvity, Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
276Section 10a, Becton, Dickinson and Company reciprocityDEF 14A—0001628280-25-057846Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include HOLOGIC INC. Filing ↗
277Section 10a, Stryker Corporation reciprocityDEF 14A—0000310764-26-000013Stryker Corporation's most recent proxy was read; its disclosed peer group does not include HOLOGIC INC. Filing ↗
278Section 10a, Integra LifeSciences Holdings Corp reciprocityDEF 14A—0000917520-26-000015Integra LifeSciences Holdings Corp names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
279Section 10a, Quest Diagnostics Inc. reciprocityDEF 14A—0001140361-26-013356Quest Diagnostics Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
280Section 10a, Baxter International Inc. reciprocityDEF 14A—0001628280-26-020330Baxter International Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
281Section 10a, Intuitive Surgical, Inc. reciprocityDEF 14A—0001035267-26-000023Intuitive Surgical, Inc.'s most recent proxy was read; its disclosed peer group does not include HOLOGIC INC. Filing ↗
282Section 10a, Bruker Corporation reciprocityDEF 14A—0001193125-26-151305Bruker Corporation names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
283Section 10a, The Cooper Companies, Inc. reciprocityDEF 14A—0001628280-26-011110The Cooper Companies, Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
284Section 10a, Agilent Technologies, Inc. reciprocityDEF 14A—0001193125-26-040286Agilent Technologies, Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
285Section 10a, Boston Scientific Corporation reciprocityDEF 14A—0000885725-26-000025Boston Scientific Corporation names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
286Section 10a, Zimmer Biomet Holdings, Inc. reciprocityDEF 14A—0001193125-26-135661Zimmer Biomet Holdings, Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
287Section 10a, IDEXX Laboratories, Inc. reciprocityDEF 14A—0000874716-26-000064IDEXX Laboratories, Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
288Section 10a, ResMed Inc. reciprocityDEF 14A—0000943819-26-000080ResMed Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
289Section 10a, STERIS plc reciprocityDEF 14A—0001193125-26-267599STERIS plc names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
290Section 10a, Mettler-Toledo International Inc. reciprocityDEF 14A—0001174947-26-000389Mettler-Toledo International Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
291Section 10a, DENTSPLY SIRONA Inc. reciprocityDEF 14A—0000818479-26-000125DENTSPLY SIRONA Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
292Section 10a, Waters Corporation reciprocityDEF 14A—0001193125-26-149657Waters Corporation names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
293Section 10a, DexCom, Inc. reciprocityDEF 14A—0001093557-26-000061DexCom, Inc. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
294Section 10a, Edwards Lifesciences Corp. reciprocityDEF 14A—0001099800-26-000015Edwards Lifesciences Corp. names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
295Section 10a, Teleflex Incorporated reciprocityDEF 14A—0000096943-26-000039Teleflex Incorporated names HOLOGIC INC in its own disclosed peer group (read from its most recent proxy). Filing ↗
296Section 10a, Johnson & Johnson reciprocityDEF 14A—0000200406-26-000063Johnson & Johnson's most recent proxy was read; its disclosed peer group does not include HOLOGIC INC. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the HOLOGIC INC Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
HOLX Peer Teardown Report